We exist to counter the massive disinformation campaign regarding the pandemic. We are diverse, exceedingly well-credentialed physicians with extensive front line experience treating COVID-19 and the risky health effects due to the lockdowns. There are many early treatment options! Most people do just fine!
There is no reason to live in fear!
- If you would like to know the facts from doctors who are passionate about giving you those facts, watch our videos, found under Summit. If you need access to early treatment go to Referral.
- If you simply want to understand what “early treatment” is, watch our “Early Treatment” video or look under HCQ Protocols.
Unlike the government, CDC, FDA, NIH or any other organization with other motives, we doctors have a fiduciary, moral, ethical, legal and spiritual obligation to help people … and that means you. We are not the media. Please share widely.
Americas Frontline Doctor Summit
As many people living in primarily Democrat run cities and states have suspected for quite sometime, Governor Cuomo admits that the lock downs are not based on any science. In Canada, several regions in Ontario are back in lock down again all but guaranteeing the final destruction of many businesses which had barely survived the first set of lock downs. Intentionally impoverishing people through the systematic destruction of their livelihood for no reason is a crime against humanity. The hardships that millions of people are having to endure as a result of these unconstitutional, and destructive lock downs is likely to endure for many years.
We randomized 115 children to trivalent inactivated influenza vaccine (TIV) or placebo. Over the following 9 months, TIV recipients had an increased risk of virologically-confirmed non-influenza infections (relative risk: 4.40; 95% confidence interval: 1.31-14.8). Being protected against influenza, TIV recipients may lack temporary non-specific immunity that protected against other respiratory viruses.
Among the 115 participants who were followed up, the median duration of follow-up was 272 days (interquartile range, 264–285 days), with no statistically significant differences in age, sex, household size, or duration of follow-up between TIV and placebo recipients (Table ). We identified 134 ARI episodes, of which 49 met the more stringent FARI case definition. Illnesses occurred throughout the study period (Supplementary Appendix Figure 1). There was no statistically significant difference in the risk of ARI or FARI between participants who received TIV and those who received placebo, either during winter or summer 2009 (Table ).
Clinical Infectious Diseases
The CDC recently revealed that the Case Fatality Rate (CFR) of COVID-19 is much less than we had previously been told. The World Health Organization originally claimed that a staggering 3.4% of people with the infection would die from it. The CDC has now come out and admitted that the true CFR is just 0.26%, 1300% lower than the original claim from the World Fearmongering Organization.
A Department of Defense study showed flu vaccine recipients were at 36% increased risk of coronavirus infection, the same family of viruses as COVID-19. A concerning finding considering Reuters is reporting that fears of a second wave are pushing pharmacies and drugmakers to gear up for a major flu vaccine push this year.
Fluzone Quadrivalent High-Dose
Within 6 months post-vaccination, 156 (6.1%) Fluzone High-Dose recipients and 93 (7.4%) Fluzone recipients experienced a serious adverse event (SAE). No deaths were reported within 28 days post-vaccination. A total of 23 deaths were reported during Days 29 – 180 post-vaccination: 16 (0.6%) among Fluzone High-Dose recipients and 7 (0.6%) among Fluzone recipients. The majority of these participants had a medical history of cardiac, hepatic, neoplastic, renal, and/or respiratory diseases. These data do not provide evidence for a causal relationship between deaths and vaccination with Fluzone High-Dose.
Elderly who generally suffer from comorbidities and have been especially hard hit by COVID-19 are dying at twice the rate of the average COVID-19 CFR following flu vaccination. When considering the apparently increased risk of coronavirus infection, as well as the normally significant death rate of the elderly who receive regular flu vaccination it appears that a major flu vaccine push could result in the dreaded “second wave” we’ve been hearing about for months now.
“The world is in the grip of the COVID-19 pandemic. Public health measures that can reduce the risk of infection and death in addition to quarantines are desperately needed. This article reviews the roles of vitamin D in reducing the risk of respiratory tract infections, knowledge about the epidemiology of influenza and COVID-19, and how vitamin D supplementation might be a useful measure to reduce risk. Through several mechanisms, vitamin D can reduce risk of infections. Those mechanisms include inducing cathelicidins and defensins that can lower viral replication rates and reducing concentrations of pro-inflammatory cytokines that produce the inflammation that injures the lining of the lungs, leading to pneumonia, as well as increasing concentrations of anti-inflammatory cytokines. Several observational studies and clinical trials reported that vitamin D supplementation reduced the risk of influenza, whereas others did not. Evidence supporting the role of vitamin D in reducing risk of COVID-19 includes that the outbreak occurred in winter, a time when 25-hydroxyvitamin D (25(OH)D) concentrations are lowest; that the number of cases in the Southern Hemisphere near the end of summer are low; that vitamin D deficiency has been found to contribute to acute respiratory distress syndrome; and that case-fatality rates increase with age and with chronic disease comorbidity, both of which are associated with lower 25(OH)D concentration. To reduce the risk of infection, it is recommended that people at risk of influenza and/or COVID-19 consider taking 10,000 IU/d of vitamin D3 for a few weeks to rapidly raise 25(OH)D concentrations, followed by 5000 IU/d. The goal should be to raise 25(OH)D concentrations above 40–60 ng/mL (100–150 nmol/L). For treatment of people who become infected with COVID-19, higher vitamin D3 doses might be useful. Randomized controlled trials and large population studies should be conducted to evaluate these recommendations.”